{
  "trial_id": "NCT00761280",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "written informed consent prior to any study-related procedure",
      "label": "met"
    },
    {
      "criterion": "age at least 18 years and equal to or below 70 years",
      "label": "met"
    },
    {
      "criterion": "present diagnosis of AA or secondary GBM",
      "label": "met"
    },
    {
      "criterion": "measurable lesion (> 1 ccm in volume, central MRI review)",
      "label": "met"
    },
    {
      "criterion": "lesion (or sum of lesions) does not exceed 50 ccm in volume (central MRI review)",
      "label": "met"
    },
    {
      "criterion": "tumor is localized supratentorially (central MRI review)",
      "label": "unknown"
    },
    {
      "criterion": "recurrent or refractory disease",
      "label": "met"
    },
    {
      "criterion": "not received more than one chemotherapy regimen",
      "label": "met"
    },
    {
      "criterion": "eligible for chemotherapy",
      "label": "met"
    },
    {
      "criterion": "on a maximum dose of 4 mg/day dexamethasone or equivalent doses for other corticosteroids, which has been stable or decreasing for at least 3 weeks prior to Screening",
      "label": "unknown"
    },
    {
      "criterion": "male or non-pregnant, non-lactating female",
      "label": "met"
    },
    {
      "criterion": "females of childbearing potential must have a negative beta-HCG pregnancy test at Screening",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "patient unable or not willing to comply with the protocol regulations",
      "label": "triggers"
    },
    {
      "criterion": "tumor surgery, tumor debulking, or other neurosurgery within 3 months prior to randomization",
      "label": "triggers"
    },
    {
      "criterion": "radiotherapy or stereotactic (gamma knife) radiosurgery within 3 months prior to randomization",
      "label": "triggers"
    },
    {
      "criterion": "prior interstitial brachytherapy of the brain with permanent implants",
      "label": "unknown"
    },
    {
      "criterion": "chemotherapy, hormone therapy, or any other therapy with established or suggested anti-tumor effects within 4 weeks (nitrosoureas: 6 weeks) prior to randomization",
      "label": "triggers"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00761280",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}